Q: is recent share decline due to proposed equity issue?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Would appreciate your evaluation of this company.
It appears to have many positive attributes including no debt.
Thanks for your valuable insights
It appears to have many positive attributes including no debt.
Thanks for your valuable insights
Q: Nuvo had a strong surge and a sudden steep drop
Any comment on this small pharme company ?
Walter
Any comment on this small pharme company ?
Walter
Q: I'm about to retire and I'm looking for:
1) A small-cap, U.S. based stock
2) Pays at least at 3% dividend
Any suggestions?
1) A small-cap, U.S. based stock
2) Pays at least at 3% dividend
Any suggestions?
Q: I would like to know is byl a buy,or wait?
Q: Can you offer any information on this company?
Thanks in advance
Ernest
Thanks in advance
Ernest
Q: Hello 5 I, Canada Pension Plan purchased 341,900 of Kelso recently and was wondering if I should get excited about this?
Q: Would appreciate your comment on this company.
Q: It looks like Kraken Sonar started trading on the Venture Exchange on Tuesday via a reverse takeover. I was greatly impressed by the images from their sonar compared to sonar in use today (reminds me of images from Avigilon cameras compared to those in use now). Can you tell me anything else about this company.
Bryon in Elmira
Bryon in Elmira
Q: What is your take on the results released yesterday? I own it. Thank you.
Q: Hi Peter,
Would like your opinion on the new Brookfield proposal with Armtec. Assuming no buyer is found, it looks like Brookfield gets the assets for the debt and the current shareholders get to keep their shares in a company with no assets or liabilities. Very unusual!
Joe
Would like your opinion on the new Brookfield proposal with Armtec. Assuming no buyer is found, it looks like Brookfield gets the assets for the debt and the current shareholders get to keep their shares in a company with no assets or liabilities. Very unusual!
Joe
Q: Please comment if you can on today's year end report and their conference call. Company seems finally to be making good progress and have attracted 2 new funds as share buyers, according to Morningstar.
Q: Hello Peter & Team
CDV up 3+% today and up 10% over the past 10 days with a substantial increase in volume yesterday & today.
Street appears to be somewhat bullish with 60% calling it a buy and 40% saying hold.
Is there a reason you can see for the recent strength? I can't find any insider trading info... can you?
They report March 9th - what should we expect?
Thanks for all you do
Gord
CDV up 3+% today and up 10% over the past 10 days with a substantial increase in volume yesterday & today.
Street appears to be somewhat bullish with 60% calling it a buy and 40% saying hold.
Is there a reason you can see for the recent strength? I can't find any insider trading info... can you?
They report March 9th - what should we expect?
Thanks for all you do
Gord
Q: I would appreciate your outlook on the recent acquisition by Chesswood. Does this news justify adding to a partial position. The market seems to approve.
Q: What are the possible reasons for the wild price swing of the last few days. Manipulation???
Q: Hi I was wondering if I could get your opinion on this stock!
Q: I'm looking at investing in growth stocks in the pharmaceutical/health sector and am looking at two specific stocks, CRH and ACRX.US I appreciate that both are small cap and there is inherent risk in both. Could you please review each of these, provide your thoughts, and which of the two if either you would recommend.
Thank you
Jim
Thank you
Jim
Q: Is XYL far enough along for investment? It's product, Xyla, is a sugar made from hardwood by-products. This form of xylitol is recommended for the sugar-sensitive. It is anti-bacterial: candy and gum made with hardwood xylitol don't cause cavities. Last night, xylitol (in general) got a plug on The Exchange. Cookies made with xylitol will be on Whole Foods shelves. This tells me public awareness is growing. Is XYL strong enough to grow? From Patti.
Q: Could you please give your opinion on their latest 1/4ly report and would you buy/hold/or sell.
Thanks
Thanks
Q: I'd like to know what your current view is on MCR. In response to a question I posed on Dec 9/14 the answer was "Macro had a very tough year; even before the recent energy sector meltdown, it experienced cost overruns on a fixed cost project, and this destroyed its profit margins. Now, sector retrenchment means there will likely be fewer opportunities for growth over the next two years. But.....it is still profitable, and very cheap. It has some debt, which may be more of a concern if there is not a recovery. After its big drop, we would consider it a hold, but would not buy any more. Note however that its small size now adds some more risks, especially in the short term while the sector tries to stabilize. We think it survives this cycle, but you will likely need to commit to it for another two years."
Yet, in a response to another persons question on Jan 16/15 you respond: "...Both stocks are very, very cheap, reflecting the debt and the sector. As far as survivability goes, much depends on how long the sector situation lasts. MCR, likely, has a better ability to reduce costs, as CET owns its equipment and when business slows it earns nothing on unused equipment. MCR insiders have much more skin in the game than CET insiders.
With the risk of the dividend cut hurting CET, we would reluctantly side with MCR today. But neither looks particularly interesting to us anymore. "
I realize that not the same person answers questions, and there was a period of time between those questions, and now...
What is your current view? Is it worth holding, or time to sell while I can still get something out of it.
Thanks for everything! Love your service!
Yet, in a response to another persons question on Jan 16/15 you respond: "...Both stocks are very, very cheap, reflecting the debt and the sector. As far as survivability goes, much depends on how long the sector situation lasts. MCR, likely, has a better ability to reduce costs, as CET owns its equipment and when business slows it earns nothing on unused equipment. MCR insiders have much more skin in the game than CET insiders.
With the risk of the dividend cut hurting CET, we would reluctantly side with MCR today. But neither looks particularly interesting to us anymore. "
I realize that not the same person answers questions, and there was a period of time between those questions, and now...
What is your current view? Is it worth holding, or time to sell while I can still get something out of it.
Thanks for everything! Love your service!